ST Invest LLC (d/b/a Trade App) is a wholly owned subsidiary of StockTwits, Inc. Securities products and services offered to self-directed investors through ST Invest LLC. ST Invest LLC is a member of the Financial Industry Regulatory Authority (FINRA) and the Securities Investor Protection Corporation (SIPC), which protects securities XSPA | Complete XpresSpa Group Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. TOPS | Complete TOP Ships Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Market Data Disclaimer | © 2020 Seeking Alpha
Jan 04, 2019
Camber Energy Inc. Camber Energy, Inc. is an independent oil and natural gas company. It engages in the acquisition, development and sale of crude oil and natural gas from various known productive FLKS Options Chain and Prices (Flex Pharma) | MarketBeat NASDAQ:FLKS Flex Pharma Options Chain and Prices Notice: This company has been marked as potentially delisted and may not be actively trading. Add. Compare. Share . Today's Range N/A. 50-Day Range. $0.57. MA: $6.86 $14.51. 52-Week Range N/A. Volume143,975 shs. Average Volume2.03 million shs. Market Capitalization$11.20 ETFs Holding FLKS | Salarius Pharmaceuticals Inc | ETF Channel FLKS Description — Salarius Pharmaceuticals Inc. Flex Pharma is a biotechnology company that is developing treatments for muscle cramps, spasms and spasticity associated with severe neurological conditions and exercise-associated muscle cramps. Co.'s primary drug product candidate, FLX-787, is in exploratory Phase 2 clinical trials in FLKS - Flex Pharma, Inc. - Stocks summary FLKS LOSS NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Flex Pharma, Inc. – FLKS finance.yahoo.com Jul 3, 2019 4:07 …
June 01, 2016 *Chairman Westphal Buys 22,300 Sahres of Flex Pharma @$12.68/Share -Form 4 Benzinga May 27, 2016 *Chairman Westphal Buys 28,600 Shares of Flex Pharma @$12.84/Share -Form 4 Benzinga
Flex Pharma, Inc. (FLKS) Company Bio. Flex Pharma is a biotechnology company that is developing innovative and proprietary treatments for Tap into the pulse of the markets and cryptocurrency trading with Stocktwits. Use StockTwits to catch up quickly on the stocks you care about and new market We estimate FLKS will burn at least 40 million of its $84 million in cash this year on clinical trials for FLX-787 and marketing spend for its new cramp supplement
FLKS / Flex Pharma, Inc. 425 - Merger Prospectus - 425. 2019-07-12 sec.gov - 11 - 425 Filed by Flex Pharma, Inc. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-6(b) under the Securities Exchange Act of 1934 Form S-4 File No.: 333-229666 Subject Company: Salarius Pharmaceuticals, LLC SEC File No.: 001-36812 Flex Pharma, Inc. intends to issue the
SELLAS Life Sciences Group. SLS 3.90 0.49 (14.23%). NASDAQ Updated Jun 8, 2020 10:22 PM Clovis Oncology, Inc. CLVS 7.20 0.25 (3.36%). NASDAQ Updated Jun 9, 2020 8:39 AM FuelCell Energy Inc. FCEL 2.75 0.05 (1.66%). NASDAQ Updated Jun 9, 2020 8:00 AM Flex Pharma, Inc. (FLKS) Growth Grade and underlying metrics. Quant Ratings. Revenue growth, EBITDA, EPS, cash flow, ROE. Compounded. Charts. Compare wtih other stocks. FLKS News: Flex Pharma Stock Rockets Higher on Salarius Merger The merger will complete in the first half of 2019 By William White , InvestorPlace Writer Jan 4, 2019, 12:53 pm EDT January 4, 2019 We are here to help the trading community Follows us on Stocktwits @vegas1 @washboardjim Anyone is welcome to also join us for a FREE Week Trial VISIT OUR NEW WEBSITE
FLEX Pharma (FLKS) Stock Message Board - InvestorsHub
Nov 01, 2017 XpresSpa Group Inc. - MarketWatch XSPA | Complete XpresSpa Group Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. NASDAQ:FLKS Flex Pharma, Inc. Stock Analysis - CapitalCube Flex Pharma, Inc. provides biopharmaceutical services. It is developing products to address muscle cramps and spasms by halting repetitive firing of the motor neurons. The company was founded by Christoph Westphal and Jennifer Cermak in February 2014 and is headquartered in Boston, MA.